Prestige Consumer Healthcare Inc. reported $1.10B of revenue over the trailing twelve months, −1.4% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.10B (to Q1 2027). Net income: $172M, trailing twelve months to Q1 2027. Free cash flow: $235M, trailing twelve months to Q1 2027. Operating margin: 26%, trailing twelve months to Q1 2027.

PBHPrestige Consumer Healthcare Inc.

Healthcare

$48.25-24% 1Y

$48.25

$44.7652 weeks$70.21

PBH as reported

Prestige Consumer Healthcare Inc. reported $1.10B of revenue over the trailing twelve months, −1.4% on the year before. 11 reported series are charted on this page, each one as filed.

$1.10B

Revenue, trailing twelve months · to Q1 2027 · −1.4% against the twelve months before

Net income: $172M
Net income · −19% year on year · trailing twelve months to Q1 2027
Free cash flow: $235M
Free cash flow · −12% year on year · trailing twelve months to Q1 2027
Operating margin: 26%
Operating margin · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for PBH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.10B	−1.4%	Q1 2027
Net income	$172M	−19%	Q1 2027
EPS	$3.57	−16%	Q1 2027
Gross margin	54%	n/a	Q1 2027
Operating margin	26%	n/a	Q1 2027
Net margin	16%	n/a	Q1 2027
ROE	10%	n/a	Q1 2027
ROA	5.1%	n/a	Q1 2027
ROIC	8.4%	n/a	Q1 2027
Free cash flow	$235M	−12%	Q1 2027
P/E	13.5	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.